The 2005 ESA Annual Meeting and Exhibition
December 15-18, 2005
Ft. Lauderdale, FL

Please note: Recorded presentations are still being processed and added to the site daily. If you granted permission to record and do not see your presentation, please keep checking back. Thank you.

Sunday, December 18, 2005 - 10:30 AM
1120

Mode of action of methoprene in the yellow fever mosquito, Aedes aegypti (L.)

Parthasarathy Ramaseshadri, parthy@uky.edu, Yu Wu, ywu4@uky.edu, Hua Bai, Hua.bai@uky.edu, and Subba Reddy Palli, rpalli@uky.edu. University of Kentucky, Entomology, S225, Agriculture Science Building North, College of Agriculture, Lexington, KY

Methoprene, a juvenile hormone analog, is used to suppress populations of mosquito by inducing mortality during metamorphosis. We investigated the mode of action of methoprene in the yellow fever mosquito, Aedes aegypti . Methoprene interfered with metamorphosis, specifically affecting replacement of larval tissues. Whole mount DNA staining of midgut tissues collected from fourth larval instar and pupal stages showed that the midgut replacement started from the posterior region and progressed anteriorly. Nuclear (DAPI) and cytosolic (Phalloidin) staining of cross-sections (5 mm) of midgut tissues confirmed these observations. Application of methoprene (0.05 mg/ml) during the fourth instar interfered with programmed cell death (PCD) of larval midgut cells and proliferation, differentiation and assembly of regenerative cells into pupal midgut. Methoprene treated larvae that undergone metamorphosis contained larval midguts up to 12 hours after pupation. Quantitative real time PCR determination of mRNA levels of genes involved in PCD showed that methoprene interfered with the expression of these genes. The mode of action of methoprene appears to involve both, preventing the removal of larval tissues and the assembly of pupal tissues.


Species 1: Diptera Culicidae Aedes aegypti (Yellow fever mosquito)
Species 2:
Species 3:
Keywords: gene expression, midgut remodeling